What is the Org number of ADMIRALEN BOLIGSAMEIE?

ADMIRALEN BOLIGSAMEIE is registered with Brønnøysundsregistrene under Org 916276206.

What is the revenue of ADMIRALEN BOLIGSAMEIE?

ADMIRALEN BOLIGSAMEIE reported revenue of NOK 2,9M in 2023.

Jørn Wårheim Bergfløtt is Deputy Member of ADMIRALEN BOLIGSAMEIE, in role since 2026.

Harald Elin Ringås chairs the board of ADMIRALEN BOLIGSAMEIE, in role since 2023.

ADMIRALEN BOLIGSAMEIE's registered address is Tassebekkveien 354, 3160 Stokke.

ESEKActive

Org 916276206Tassebekkveien 354, 3160 StokkeActivities of households as employers of domestic personnel · NACE 9700Est. 20150 employeesusbl.no

Actively employed in the business

Name	Role	Member since
Current (2)
JW Jørn Wårheim Bergfløtt Deputy Member	Deputy Member	2026
ON Otto Næss Deputy Member	Deputy Member	2023
Former (2)
KT Kjetil Tokle Deputy Member	Deputy Member	2019 – 2022
HF Haldor Fottland Deputy Member	Deputy Member	2022 – 2023

Non-executive oversight

Name	Role	Member since
Current (8)
LM Lars Martin Fure	Board of Directors	2026
SD Sonja Danielle Wiese	Board of Directors	2025
JB Jonathan Bogen Jacobsen	Board of Directors	2026
MW Madelene Wårheim Bergfløtt	Board of Directors	2022
ES Eline Stensbøl	Board of Directors	2026
KM Kathrine Myklebust	Board of Directors	2025
GE Gard Eliassen	Board of Directors	2024
SM Ståle Myklebust	Chairman	2024
Former (10)
CF Camilla Fure	Board of Directors	2023 – 2025
KG Kristoffer Grinnbo Høyum	Board of Directors	2022 – 2023
HE Harald Elin Ringås	Chairman	2023 – 2024
RH Reidun Havnes	Board of Directors	2019 – 2022
PH Per Harder Reine	Chairman	2022 – 2023
ML Mona Lia	Board of Directors	2019 – 2022
RG Ragnhild Guribye	Board of Directors	2022 – 2022
HE Håkon Erlend Ellingsen	Board of Directors	2019 – 2022
RB Rønnaug Beate Mork	Board of Directors	2022 – 2022
FL Fredrik Langø Berg	Board of Directors	2023 – 2025

As of last annual report

No shareholder data available.

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.